Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

24 Mar 2023 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated March 24, 2023 titled ‘Zydus receives final Approval from the USFDA for Doxepin Hydrochloride Capsules USP, 150 mg’.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1906.15
Dr. Reddys Labs. 1379.30
Cipla 1402.45
Lupin 2021.90
Zydus Lifesciences 1213.50
View more..